Hunter R. Murdock is General Counsel of Axsome Therapeutics, Inc.. Currently has a direct ownership of 0 shares of AXSM, which is worth approximately $0. The most recent transaction as insider was on Jun 18, 2025, when has been sold 7,500 shares (Common Stock) at a price of $100.9 per share, resulting in proceeds of $756,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

Hunter R. Murdock Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2025
SELL
Open market or private sale
$756,750 $100.9 p/Share
7,500 Reduced 100.0%
0 Common Stock
Jun 18 2025
BUY
Exercise of conversion of derivative security
$224,325 $29.91 p/Share
7,500 Added 50.0%
7,500 Common Stock
Jun 17 2025
SELL
Open market or private sale
$751,950 $100.26 p/Share
7,500 Reduced 100.0%
0 Common Stock
Jun 17 2025
BUY
Exercise of conversion of derivative security
$224,325 $29.91 p/Share
7,500 Added 50.0%
7,500 Common Stock
Jun 16 2025
SELL
Open market or private sale
$768,150 $102.42 p/Share
7,500 Reduced 100.0%
0 Common Stock
Jun 16 2025
BUY
Exercise of conversion of derivative security
$224,325 $29.91 p/Share
7,500 Added 50.0%
7,500 Common Stock
HRM

Hunter R. Murdock

General Counsel
New York, NY

Track Institutional and Insider Activities on AXSM

Follow Axsome Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXSM shares.

Notify only if

Insider Trading

Get notified when an Axsome Therapeutics, Inc. insider buys or sells AXSM shares.

Notify only if

News

Receive news related to Axsome Therapeutics, Inc.

Track Activities on AXSM